The melanocortin system

American Journal of Physiology - Endocrinology and Metabolism

Volumn 284, Issue 3 47-3, 2003, Pages

  Gantz, Ira ^a   Fong, Tung M ^b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Inflammation; Obesity; Pigmentation; Receptor; Sexual function

Indexed keywords

MELANOCORTIN; MELANOCORTIN RECEPTOR;

ENERGY BALANCE; INFLAMMATION; PIGMENTATION; PRIORITY JOURNAL; SEXUAL FUNCTION; SHORT SURVEY;

EID: 0037372451     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.00434.2002     Document Type: Short Survey

References (54)

1. Argiolas A. Neuropeptides and sexual behavior. Neurosci Biobehav Rev 8: 1127-1142, 1999.
2. Argiolas A, Melis MR, Murgia S, and Schiöth HB. ACTH-and α-MSH-induced grooming, stretching, yawning and penile erection in male rats: site of action in the brain and role of melanocortin receptors. Brain Res Bull 51: 425-434, 2000.
3. Brady LS, Smith MA, Gold PW, and Herkenham H. Altered expression of hypothalamic neuropeptide mRNAs in food-restricted and food-deprived rats. Neuroendocrinology 52: 441-447, 1990.
4. Brent WD, Didier B, Kaelin CB, Ollmann MM, Gantz I, Watson SJ, and Barsh GS. Physiological and anatomical circuitry between agouti-related protein and leptin signaling. Endocrinology 140: 2387-2397, 1999.
5. Broberger C, Johansen J, Brismar H, Johansson C, Schalling M, and Hökfelt T. Changes in neuropeptide Y receptors and pro-opiomelanocortin in the anorexia (anx/anx) mouse hypothalamus. J Neurosci 19: 7130-7139, 1999.
6. Bultman SJ, Michaud EJ, and Woychik RP. Molecular characterization of the mouse agouti locus. Cell 71: 1195-1204, 1992.
7. Buggy JJ. Binding of α-melanocyte-stimulating hormone to its G-protein-coupled receptor on B-lymphocytes activates the Jak/Stat pathway. Biochern J 331: 211-216, 1998.
8. Catania A, Airaghi L, Colombo G, and Lipton JM. α-Melanocyte-stimulating hormone in normal human physiology and disease states. Trends Endocrinol Metab 11: 304-308, 2000.
9. Chhajlani V. Distribution of cDNA for melanocortin receptor subtypes in human tissues. Biochem Mol Biol Int 38: 73-80, 1996.
10. Chen AS, Marsh DJ, Trumbauer ME, Frazier EG, Guan X-M, Yu H, Rosenblum CI, Vongs A, Feng Y, Cao L, Metzger JM, Strack AM, Camacho RE, Mellin TN, Nunes CN, Min W, Fisher J, Gopal-Truter S, MacIntyre DE, Chen HY, and Van der Ploeg LHT. Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass. Nat Genet 26: 97-102, 2000.
11. Chen W, Kelly MA, Opitz-Araya X, Thomas RE, Low MJ, and Cone RD. Exocrine gland dysfunction in MC5-R-deficient mice: evidence for coordinated regulation of exocrine gland function by melanocortin peptides. Cell 91: 789-798, 1997.
12. Cowley MA, Smart JL, Rubinstein M, Cerdan MG, Diano S, Horvath TL, Cone RD, and Low MJ. Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus. Nature 411: 480-484, 2001.
13. Dinulescu DM and Cone RD. Agouti and agouti-related protein: analogies and contrasts. J Biol Chem 275: 6695-6698, 2000.
14. Dinulescu DM, Fan W, Boston BA, McCall K, Lamoreux ML, Moore KJ, Montagno J, and Cone RD. Mahogany (mg) stimulates feeding and increases basal metabolic rate independent of its suppression of agouti. Proc Natl Acad Sci USA 95: 12707-12712, 1998.
15. Englaro W, Rezzonico R, Durand-Clément M, Lallemand D, Ortonne J-P, and Ballotti R. Mitogen-activated protein kinase pathway and AP-1 are activated during cAMP induced melanogenesis in B-16 melanoma cells. J Biol Chem 270: 24315-24320, 1995.
16. Fan W, Boston BA, Kesterson RA, Hruby VJ, and Cone RD. Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature 385: 165-168, 1997.
17. Fan W, Marks DL, Haqq A, Weissman A, Rene P, Cowley M, Takahashi K, Simerly R, Low M, Chagnon Y, and Cone RD. Mechanisms of melanocortin action in the CNS (Abstract). Proc. Int. Melanocortin Mtg. 5th Sun River CO 2002.
18. Gunn TM, Miller KA, He L, Hyman RW, Davis RW, Azarani A, Schlossman SF, Duke-Cohan JS, and Barsh GS. The mouse mahogany locus encodes a transmembrane form of human attractin. Nature 398: 152-156, 1999.
19. He L, Gunn TM, Bouley DM, Lu XY, Watson SJ, Schlossman SF, Duke-Cohan JS, and Barsh GS. A biochemical function for attractin in agouti-induced pigmentation and obesity. Nat Genet 27: 40-7, 2001.
20. Heisler LK, Cowley MA, Tecott LH, Fan W, Low MJ, Smart JL, Rubinstein M, Tatro JB, Marcus JN, Holstege H, Lee CE, Cone RD, and Elmquist JK. Activation of central melanocortin pathways by fenfluramine. Science 297: 609-611, 2002.
21. Huszar D, Lynch CA, Fairchild-Huntress V, Dunmore JH, Fang Q, Berkemeier LR, Gu W, Kesterson RA, Boston BA, Cone RD, Smith FJ, Campfield LA, Burn P, and Lee F. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 88: 131-141, 1997.
22. Jackson RS, Creemers JWM, Ohagi S, Raffin-Sanson M-L, Sanders L, Montague CT, Hutton JC, and O'Rahilly S. Obesity and impaired prohormone processing associated with mutations in the human prohormone convertase 1 gene. Nat Genet 16: 303-306, 1997.
23. Kapas S, Purbrick A, and Hinson JP. Role of tyrosine kinase and protein kinase C in the steroidogenic actions of angiotensin II, alpha-melanocyte-stimulating hormone and corticotropin in the rat adrenal cortex. Biochem J 305: 433-438, 1995.
24. Kojima I, Kojima K, and Rasmussen H. Role of calcium and cAMP in the action of adrenocorticotropin on aldosterone secretion. J Biol Chem 260: 4248-4256, 1985.
25. Konda Y, Gantz I, DelValle J, Shimoto Y, Miwa H, and Yamada T. Interaction of dual intracellular signaling pathways activated by the melanocortin-3 receptor. J Biol Chem 269: 13162-13166, 1994.
26. Krude H, Biebermann H, Werner L, Horn R, Brabant G, and Grüters A. Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans. Nat Genet 19: 155-157, 1998.
27. Lechan RM and Tatro JB. Hypothalamic melanocortin signaling in cachexia. Endocrinology 142: 3288-3291, 2001.
28. Lindblom J, Kask A, Hagg E, Harmark L, Bergstrom L, and Wikberg J. Chronic infusion of a melanocortin receptor agonist modulates dopamine receptor binding in the rat brain. Pharmacol Res 45: 119-124, 2002.
29. Lindblom J, Opmane B, Mutulis F, Mutule I, Petrovska R, Klusa R, Bergstrom L, and Wikberg JE. The MC4 receptor mediates α-MSH induced release of nucleus accumbens dopamine. Neuroreport 12: 2155-2158, 2001.
30. Lu D, Willard D, Patel IR, Kadwell S, Overton L, Kost T, Luther M, Chen W, Woychik RP, Wilkison WO, and Cone RD. Agouti protein is an antagonist of the melanocyte-stimulating-hormone receptor. Nature 371: 799-802, 1994.
31. Luger TA, Schwarz H, Scholzen KT, Schwarz A, and Brzoska T. Role of epidermal cell-derived α-melanocyte stimulating hormone in ultraviolet light mediated local immunosuppresssion. Ann NY Acad Sci 885: 209-216, 1999.
32. McNulty JC, Thompson DA, Bolin KA, Wilken J, Barsh GS, and Millhauser GL. High-resolution NMR structure of the chemically-synthesized melanocortin receptor binding domain AGRP(87-132) of the agouti-related protein. Biochemistry 40: 15520-15527, 2001.
33. Nijenhuis WA, Oosterom J, and Adan RAH. AGRP(87-132) acts as an inverse agonist on the human-melanocortin-4 receptor. Mol Endocrinol 15: 164-171, 2001.
34. Ollmann MM, Wilson BD, Yang Y-K, Kerns JA, Chen Y, Gantz I, and Barsh GS. Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein. Science 278: 135-138, 1997.
35. Pritchard LE, Turnbull AV, and White A. Pro-opiomelanocortin processing in the hypothalamus: impact on melanocortin signaling and obesity. J Endocrinol 172: 411-421, 2002.
36. Qian S, Chen H, Weingarth D, Trumbauer ME, Novi DE, Guan X, Yu H, Shen Z, Feng Y, Frazier E, Chen A, Camacho RE, Shearman LP, Gopal-Truter S, MacNeil DJ, Van der Ploeg LH, and Marsh DJ. Neither agouti-related protein nor neuropeptide Y is critically required for the regulation of energy homeostasis in mice. Mol Cell Biol 22: 5027-5035, 2002.
37. Reizes O, Lincecum J, Wang Z, Goldberger O, Huang L, Kaksonen M, Ahima R, Hinkes MT, Barsh GS, Rauvala H, and Bernfield M. Transgenic expression of syndecan-1 uncovers a physiological control of feeding behavior by syndecan-3. Cell 106: 105-116, 2001.
38. Robbins LS, Nadeau JH, Johnson KR, Kelly MA, Roselli-Rehfuss L, Baack E, Mountjoy KG, and Cone RD. Pigmentation phenotypes of variant extension locus alleles result from point mutations that alter MSH receptor function. Cell 72: 827-834, 1993.
39. Schaffer JV and Bolognia JL. The melanocortin-1 receptor: red hair and beyond. Arch Dermatol 137: 1477-1485, 2001.
40. Shen CP, Wu KK, Shearman LP, Camacho R, Tota MR, Fong TM, and Van der Ploeg LH. Plasma agouti-related protein level: a possible correlation with fasted and fed states in humans and rats. J Neuroendocrinol 14: 607-610, 2002.
41. Thody AJ. α-MSH and the regulation of melanocyte function. Ann NY Acad Sci 885: 217-229, 1999.
42. Thody AJ, Cooper MF, Bowden PE, Meddis D, and Shuster S. Effect of α-melanocyte-stimulating hormone and testosterone on cutaneous and modified sebaceous glands in the rat. J Endocrinol 71: 279-288, 1976.
43. Thody AJ, Wilson CA, and Everard D. Facilitation and inhibition of sexual receptivity in the female rat by α-MSH. Physiol Behav 22: 447-450, 1979.
44. Tsigo C, Arai K, Hung W, and Chrousos GP. Hereditary isolated glucocorticoid deficiency is associated with abnormalities of the adrenocorticotropin receptor gene. J Clin Invest 92: 2458-2461, 1993.
45. Vaisse C, Clement K, Durand E, Hercberg S, Guy-Grand B, and Froguel P. Melanocortin-4 receptor mutations are a frequent and heterogeneous cause of morbid obesity. J Clin Invest 106: 253-62, 2000.
46. Valverde P, Healy E, Jackson I, Rees JL, and Thody AJ. Variants of the melanocyte-stimulating hormone receptor gene are associated with red hair and fair skin in humans. Nat Genet 11: 328-330, 1995.
47. Van der Ploeg LHT, Martin WJ, Howard AD, Nargund RP, Austin CP, Guan X, Drisko J, Cashen D, Sebhat I, Patchett AA, Figueroa DJ, DiLella AG, Connolly BM, Weinberg DH, Tan CP, Palyha OC, Pong S-S, MacNeil T, Rosenblum C, Vongs A, Tang R, Yu H, Sailer AW, Fong TM, Huang C, Tota MR, Chang RS, Stearns R, Tamvakopoulos C, Christ G, Drazen DL, Spar DB, Nelson J, and MacIntyre DE. A role for the melanocortin 4 receptor in sexual function. Proc Natl Acad Sci USA 99: 11381-11386, 2002.
48. Vergoni AV, Poggioli R, and Bertonlini A. Corticotropin inhibits food intake in rats. Neuropeptides 7: 153-158, 1986.
49. Vrieling H, Duhl DM, Millar SE, Miller KA, and Barsh GS. Differences in dorsal and ventral pigmentation result from regional expression of the mouse agouti gene. Proc Natl Acad Sci USA 91: 5667-5671, 1994.
50. Wessells H, Fuciarelli K, Hansen J, Hadley ME, Hruby VJ, Dorr R, and Levine N. Synthetic melanotropic peptide initiates erections in men with psychogenic erectile dysfunction: double-blind placebo controlled crossover study. J Urol 160: 389-393, 1998.
51. Wessells H, Gralnek D, Dorr R, Hruby VJ, Hadley ME, and Levin N. Effect of an alpha-melanocyte stimulating hormone analog on penile erection and sexual desire in men with organic erectile dysfunction. Urology 56: 641-646, 2002.
52. Wikberg JES. Melanocortin receptors: perspectives for novel drugs. Eur J Pharmacol 375: 295-310, 1999.
53. Williams DL, Kaplan JM, and Grill HJ. The role of the dorsal vagal complex and the vagus nerve in feeding effects of melanocortin-3/4 receptor stimulation. Endocrinology 141: 1332-1337, 2000.
54. Wilson BD, Ollmann MM, Kang L, Stoffel M, Bell GI, and Barsh GS. Structure and function of ASP, the human homolog of the mouse agouti gene. Hum Mol Genet 4: 223-230, 1995.